This paper reports the case of a platinum-sensitive patient who developed moderately differentiated squamous cell carcinoma of the oral cavity after exposure to pegylated liposomal doxorubicin (PLD). The authors conclude that identification of patients at major risk of PLD-related secondary malignancies and strategies for early detection and reduction of oral carcinogenesis are priorities for future study.
No clinical trial protocols linked to this paper
Clinical trials are automatically linked when NCT numbers are found in the paper's title or abstract.PICO Elements
No PICO elements extracted yet. Click "Extract PICO" to analyze this paper.
Paper Details
MeSH Terms
Associated Data
No associated datasets or code repositories found for this paper.
Related Papers
Related paper suggestions will be available in future updates.